Načítá se...
Systemic treatment for advanced urothelial cancer: an update on recent clinical trials and current treatment options
After cisplatin-based chemotherapy became the standard treatment for metastatic urothelial cancer (mUC), very little progress has been made in the treatment landscape of this condition until recently. With increased knowledge about the molecular biology of mUC and advances in the field of cancer imm...
Uloženo v:
| Vydáno v: | Korean J Intern Med |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Korean Association of Internal Medicine
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7373963/ https://ncbi.nlm.nih.gov/pubmed/32668516 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2020.204 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|